Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients: The ACHIEV2E Collaboration Study Group.
Stichting HIV Monitoring, Amsterdam, the NetherlandsStichting HIV Monitoring, Amsterdam
Hospital de Santa Maria, Clinica Universitaria de Doenças Infecciosas, Lisbon, PortugalHospital de Santa Maria, Clinica Universitaria de Doenças Infecciosas, Lisbon
Hospital Carlos III, Department of Infectious Diseases, Madrid, SpainHospital Carlos III, Department of Infectious Diseases, Madrid
Hôpitaux Universitaires de Genève, Service de Maladies Infectieuses, Unite VIH/SIDA, Geneva, SwitzerlandHôpitaux Universitaires de Genève, Service de Maladies Infectieuses, Unite VIH/SIDA, Geneva
University of Milan, Department of Clinical Sciences "L. Sacco", Section of Infectious Diseases, Milan, ItalyUniversity of Milan, Department of Clinical Sciences "L. Sacco", Section of Infectious Diseases
APHP, Hôpital Bichat - Claude Bernard, Laboratoire de Virologie; Paris VII Denis Diderot UniversityAPHP, Hôpital Bichat - Claude Bernard, Laboratoire de Virologie; Paris VII Denis Diderot University
INSERM, U897; University Bordeaux SegalenINSERM, U897; University Bordeaux Segalen
Paris VII Denis Diderot University; APHP, Hôpital Bichat-Claude Bernard, Service de Maladies infectieuses et Tropicales, Paris, FranceParis VII Denis Diderot University; APHP, Hôpital Bichat-Claude Bernard, Service de Maladies infectieuses et Tropicales
Citations
APA
Chicago
FWB
Benard, A., van Sighem, A., Taieb, A., Valadas, E., Ruelle, J., Soriano, V., Calmy, A., Balotta, C., Damond, F., Brun-Vezinet, F., Chene, G., & Matheron, S. (2011). Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients: The ACHIEV2E Collaboration Study Group. Clinical Infectious Diseases. https://doi.org/10.1093/cid/cir123